NPC1L1 (Niemann–Pick C1-Like 1) is best known as a key mediator of intestinal cholesterol absorption and a target for cholesterol-lowering drugs (e.g., ezetimibe). Increasing evidence suggests that NPC1L1 may also play a role in cancer biology.
Overall, NPC1L1 is emerging as a potential biomarker of altered lipid metabolism in cancer, and future studies may help clarify its utility as a prognostic indicator or therapeutic target.
(Will delete Record if Target field = "Delete") Home